Clinical-economic appropriateness of drug treatments: designing a method that combines evidence-based information and cost assessments to construct league tables accounting for the potential number of patients

By Messori Andrea   Santarlasci Benedetta   Trippoli Sabrina   Vaiani Monica   Vacca Franca   Brutti M Chiara  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2381-2389

Informa Healthcare

Access to resources Recommend Favorite

Drug Metabolism and Drug Interactions: Application and Clinical Value of In Vitro Models

By  

Current Drug Metabolism, Vol. 4, Iss. 5, 2003-10 ,pp. : 423-459

Bentham Science Publishers

Access to resources Recommend Favorite

More drug information required by UK patients

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 425, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Sorafenib: activity and clinical application in patients with hepatocellular carcinoma

By Guan Yong-Song   He Qing  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 303-313

Informa Healthcare

Access to resources Recommend Favorite

Drug Treatment Outcomes for Persons on Waiting Lists

By Chun JongSerl   Guydish Joseph   Silber Ellen   Gleghorn Alice  

The American Journal of Drug and Alcohol Abuse, Vol. 34, Iss. 5, 2008-09 ,pp. : 526-533

Informa Healthcare

Access to resources Recommend Favorite